Restoring Dystrophin via Exon Skipping Strategies -- PPMD 2022 Annual Conference

Gene Therapy Approaches To Replace Or Restore Dystrophin -- Ppmd 2022 Annual Conference

Ppmd 2018 Conference - Restoring Or Replacing Dystrophin

Research Row Breakout Session: Exon Skipping Strategies - Ppmd 2023 Annual Conference

In The Pipeline: Next-gen Exon Skipping (ppmd's 2021 Virtual Annual Conference)

Advancements In Cell & Gene Therapy -- Ppmd 2023 Annual Conference

New Hope For Young Duchenne Muscular Dystrophy Patients In Australia | 7news

Ep.40 Preject Restore Lc135 V2

Gene Therapy May Leave Patients At Higher Risk Of Cancer - Dr. Adi Barzel

In The Pipeline: Restoring Dystrophin - Sarepta Therapeutics (rna Targeted Therapies)

In The Pipeline: Restoring Dystrophin - Day 2 - Ppmd Annual 2020

In The Pipeline: Dystrophin Restoration (ppmd's 2021 Virtual Annual Conference)

Gene Therapy: The Power Of Advocacy & Real World Evidence -- Ppmd 2023 Annual Conference

Brain And Behavior -- Ppmd 2022 Annual Conference

Keynote: Lessons Learned In Duchenne - Ppmd 2022 Annual Conference

The Future Of Genetic Therapies -- Ppmd 2022 Annual Conference

2022 Futures Exon Skipping And Read Through Agents Panel

Webinar: Viltepso, An Fda-approved Treatment For Patients Amenable To Exon 53 Skipping (march 2023)

Ppmd 2019 Conference - Crispr: Future Strategies In Gene Therapy

Duchenne Landscape Now Research & Trials Progress -- Ppmd 2023 Annual Conference

Ppmd 2018 Conference - Gene Editing: A Strategy For The Future & Live Polling

Hope & The Present Moment -- Ppmd 2022 Annual Conference